Sun Pharma might soon be able to free itself of whistleblower allegations weighing on its shares—at least from the securities watchdog’s point of view.
The UK’s Medicines and Healthcare products Regulatory Agency is considering whether to allow over-the-counter sales of erectile dysfunction drug sildenafil, which was originally on the...